44 related articles for article (PubMed ID: 12774054)
1. Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.
Burns DM; Rana S; Martin E; Nagra S; Ward J; Osman H; Bell AI; Moss P; Russell NH; Craddock CF; Fox CP; Chaganti S
Bone Marrow Transplant; 2016 Jun; 51(6):825-32. PubMed ID: 26901708
[TBL] [Abstract][Full Text] [Related]
2. Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event.
Burns DM; Tierney R; Shannon-Lowe C; Croudace J; Inman C; Abbotts B; Nagra S; Fox CP; Chaganti S; Craddock CF; Moss P; Rickinson AB; Rowe M; Bell AI
Blood; 2015 Dec; 126(25):2665-75. PubMed ID: 26450987
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.
Shaffer DR; Rooney CM; Gottschalk S
Immunotherapy; 2010 Sep; 2(5):663-71. PubMed ID: 20874650
[TBL] [Abstract][Full Text] [Related]
4. Transplanting One Problem for Another.
Borst AJ; Wechsler DS
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557771
[No Abstract] [Full Text] [Related]
5. Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood.
Bomken S; Skinner R
Children (Basel); 2015 Apr; 2(2):146-73. PubMed ID: 27417356
[TBL] [Abstract][Full Text] [Related]
6. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.
Ullmann AJ; Schmidt-Hieber M; Bertz H; Heinz WJ; Kiehl M; Krüger W; Mousset S; Neuburger S; Neumann S; Penack O; Silling G; Vehreschild JJ; Einsele H; Maschmeyer G;
Ann Hematol; 2016 Sep; 95(9):1435-55. PubMed ID: 27339055
[TBL] [Abstract][Full Text] [Related]
7. B-Cell-Rich T-Cell Lymphoma Associated with Epstein-Barr Virus-Reactivation and T-Cell Suppression Following Antithymocyte Globulin Therapy in a Patient with Severe Aplastic Anemia.
Hanaoka N; Murata S; Hosoi H; Shimokado A; Mushino T; Kuriyama K; Hatanaka K; Nishikawa A; Kurimoto M; Sonoki T; Muragaki Y; Nakakuma H
Hematol Rep; 2015 Sep; 7(3):5906. PubMed ID: 26487932
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.
Mensen A; Na IK; Häfer R; Meerbach A; Schlecht M; Pietschmann ML; Gruhn B
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1971-80. PubMed ID: 24962343
[TBL] [Abstract][Full Text] [Related]
9. Double umbilical cord blood transplantation for children and adolescents.
Kang HJ; Yoo KH; Lee JW; Kim H; Lee SH; Sung KW; Park KD; Koo HH; Shin HY; Ahn HS
Ann Hematol; 2010 Oct; 89(10):1035-44. PubMed ID: 20508938
[TBL] [Abstract][Full Text] [Related]
10. Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation.
Blaes AH; Cao Q; Wagner JE; Young JA; Weisdorf DJ; Brunstein CG
Biol Blood Marrow Transplant; 2010 Feb; 16(2):287-91. PubMed ID: 19835968
[TBL] [Abstract][Full Text] [Related]
11. Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.
Scheinberg P; Fischer SH; Li L; Nunez O; Wu CO; Sloand EM; Cohen JI; Young NS; John Barrett A
Blood; 2007 Apr; 109(8):3219-24. PubMed ID: 17148582
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for steroid-refractory chronic graft-versus-host disease.
Cutler C; Miklos D; Kim HT; Treister N; Woo SB; Bienfang D; Klickstein LB; Levin J; Miller K; Reynolds C; Macdonell R; Pasek M; Lee SJ; Ho V; Soiffer R; Antin JH; Ritz J; Alyea E
Blood; 2006 Jul; 108(2):756-62. PubMed ID: 16551963
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant lymphoproliferative disease: pathogenesis, monitoring, and therapy.
Ambinder RF
Curr Oncol Rep; 2003 Sep; 5(5):359-63. PubMed ID: 12895385
[TBL] [Abstract][Full Text] [Related]
14. Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation.
Gruhn B; Meerbach A; Häfer R; Zell R; Wutzler P; Zintl F
Bone Marrow Transplant; 2003 Jun; 31(11):1023-5. PubMed ID: 12774054
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
[TBL] [Abstract][Full Text] [Related]
16. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.
Ahmad I; Cau NV; Kwan J; Maaroufi Y; Meuleman N; Aoun M; Lewalle P; Martiat P; Crokaert F; Bron D
Transplantation; 2009 Apr; 87(8):1240-5. PubMed ID: 19384173
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
[TBL] [Abstract][Full Text] [Related]
18. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
Styczynski J; Einsele H; Gil L; Ljungman P
Transpl Infect Dis; 2009 Oct; 11(5):383-92. PubMed ID: 19558376
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
Meijer E; Cornelissen JJ
Curr Opin Hematol; 2008 Nov; 15(6):576-85. PubMed ID: 18832928
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
